Clinical Trial: Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

---

Official Title: Postmarketing Surveillance Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in the Republic of Korea

Brief Summary:

The purpose of the study is to perform the re-examination of Menactra® administered in the routine clinical settings in accordance with the Ministry of Food and Drug Safety regulation.

Primary objective:

• To describe the safety profile after 1 dose of Menactra® administered from 9 months to 55 years of age under standard health care practice.